In Vitro Activities of Novel Des-Fluoro(6) Quinolone BMS-284756 against Mutants of Streptococcus pneumoniae , Streptococcus pyogenes , and Staphylococcus aureus Selected with Different Quinolones
Open Access
- 1 March 2002
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (3) , 934-935
- https://doi.org/10.1128/aac.46.3.934-935.2002
Abstract
BMS-284756 (T-3811) is a novel quinolone that lacks a fluorine at the C-6 position. BMS-284756 has a broad spectrum of antibacterial activity ([3][1], [7][2]). The purpose of the present study was (i) to analyze the in vitro activity of the novel quinolone against mutants of Streptococcus pneumoniaeKeywords
This publication has 7 references indexed in Scilit:
- In Vitro Development of Resistance to Six Quinolones in Streptococcus pneumoniae, Streptococcus pyogenes , and Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2001
- Antibacterial Spectrum of a Novel Des-Fluoro(6) Quinolone, BMS-284756Antimicrobial Agents and Chemotherapy, 2000
- Resistance to Multiple Fluoroquinolones in a Clinical Isolate of Streptococcus pyogenes : Identification of gyrA and parC and Specification of Point Mutations Associated with ResistanceAntimicrobial Agents and Chemotherapy, 2000
- Prevalence of gyrA , gyrB , parC , and parE Mutations in Clinical Isolates of Streptococcus pneumoniae with Decreased Susceptibilities to Different Fluoroquinolones and Originating from Worldwide Surveillance Studies during the 1997-1998 Respiratory SeasonAntimicrobial Agents and Chemotherapy, 2000
- Antipneumococcal Activities of Gemifloxacin Compared to Those of Nine Other AgentsAntimicrobial Agents and Chemotherapy, 2000
- In Vitro and In Vivo Antimicrobial Activities of T-3811ME, a Novel Des-F(6)-QuinoloneAntimicrobial Agents and Chemotherapy, 1999
- Characterization of grlA , grlB , gyrA , and gyrB Mutations in 116 Unrelated Isolates of Staphylococcus aureus and Effects of Mutations on Ciprofloxacin MICAntimicrobial Agents and Chemotherapy, 1998